Frontline treatment of CD30+peripheral T-cell lymphomas with brentuximab vedotin in combination with CHP: 3-year durability and survival follow-up Meeting Abstract
| Authors: | Horwitz, S. M.; Shustov, A. R.; Forero-Torres, A.; Bartlett, N. L.; Advani, R.; Pro, B.; Chen, R.; Davies, A. J.; Illidge, T.; Huebner, D.; Kennedy, D. A.; Fanale, M. A. |
| Abstract Title: | Frontline treatment of CD30+peripheral T-cell lymphomas with brentuximab vedotin in combination with CHP: 3-year durability and survival follow-up |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019005015 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.1537.1537 |
| Notes: | Meeting Abstract: 1537 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
